Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Acetaminophen toxicity revisited in JAMA; further study of risk factors urged by researchers.

This article was originally published in The Tan Sheet

Executive Summary

ACETAMINOPHEN TOXICITY STUDY REVISITED IN JAMA: "further investigation" is needed to determine the "relative magnitude of risk contributed by each factor" associated with acetaminophen toxicity, David Whitcomb, MD/PhD, and Geoffrey Block, MD/MPH, University of Pittsburgh, said in the July 26 Journal of the American Medical Association. Whitcomb and Block's comments to letters responded to the editor regarding a study they authored in the Dec. 21, 1994 JAMA on the association of acetaminophen toxicity with fasting and ethanol use ("The Tan Sheet" Jan. 2, pp. 10-11).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084131

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel